Replies to post #35180 on Imaging Diagnostic Systems (fka IMDS)

[$treet $inatra]

$IMDS shorty getting desperate to cover $SQUEEEZE$$$$$

[tradeho]

So buy mine!!! I have had a sell order ( good til cancelled) since last Wednesday, six trading days ago. At that time there were just over 92 million shares on ask. We have seen over 400 million shares trade at 0002, yet my order still sits. Buy all day....good luck ever selling on ask, won't happen. I will have to sell at 0001 if I want any money back. So by all means, buy em up and take it in the backside.


IMO

[$treet $inatra]

$IMDS having some monster ask slaps, .0003 close?

[$treet $inatra]

IMDS Ministry of Health Approval in Kuwait to.Distribute.CTLM(R) http://www.bloomberg.com/article/2013-05-14/avUV.aK0wiEE.html

http://www.imds.com/

IDSI Announces Ministry of Health Approval in Kuwait to Distribute CTLM(R),
the innovative 3D Laser Breast Imaging System

FORT LAUDERDALE, Fla., May 14, 2013 (GLOBE NEWSWIRE) -- Imaging Diagnostic
Systems, Inc. (OTC:IMDS), a pioneer in laser breast imaging, announced today
that it has received approval from the Ministry of Health in Kuwait to market
and sell its innovative CTLM® in that country. Mareen Group Co., the exclusive
distributor of CTLM® in Kuwait, has worked hard to achieve this significant
accomplishment.

desc

Ahmad Abdulrahman, General Manager of Mareen Group Co., comments: "We are
honored and extremely pleased to achieve the approval of the Ministry of
Health in Kuwait for the CTLM®. The CTLM® offers Kuwaiti women an imaging
method without radiation, compression or contrast agents. In addition, the
encouraging results of the published paper in the March 2013 edition of
Clinical Imaging, a radiologist peer reviewed journal, shows the potential for
this amazing modality. The results from that study, "CTLM® could distinguish
benign lesions from malignant lesions and is not affected by breast density"
are very important, especially regarding the dense breast population in
Kuwait. Through upcoming installations, the women of Kuwait will hopefully
benefit from this non-invasive and dignified option.

We are very excited and honored to announce the Kuwaiti Ministry of Health
approval. This helps IDSI, through the efforts of Mareen Group Co., to expand
the availability of CTLM® in the Middle East," said Linda Grable, CEO of
Imaging Diagnostic Systems, Inc. "Mareen Group Co. is an established and
successful distributor who will assist our efforts to increase worldwide use
and adoption of CTLM®. Our success in receiving this approval in Kuwait should
help us continue to drive the acceptance of the CTLM® worldwide; thereby
assisting women's imaging needs."

Imaging Diagnostic Systems, Inc. is the developer of the CTLM® system; a
revolutionary optical breast imaging device. Optical mammography is a diffuse
optical tomography (DOT) technique that aims at detecting breast cancer. The
CTLM® system utilizes patented continuous wave laser technology and computed
algorithms to create 3D images of the breast. The procedure is non-invasive,
painless, and does not expose the patient to ionizing radiation or painful
breast compression. The CTLM® system has received certification and licenses
to sell internationally through the following approvals; European CE marking,
Health Canada, China SFDA, UL, ISO 13485:2003, FDA export certification.
Marketing clearances pending are Mexico COFEPRIS and Russian GOST-R.

For more information, visit our website: http://www.imds.com